LONDON BROKER RATINGS: Berenberg cuts Haleon, Barclays cuts Dr Martens
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 286.40p on 02-11-2026 at 16:50:34 |
|---|---|
| Change | 1.60p 0.56% |
| Buy | 285.00p |
| Sell | 284.60p |
| Last Trade: | Sell 252,970.00 at 286.40p |
| Day's Volume: | 822,576 |
| Last Close: | 286.40p |
| Open: | 295.20p |
| ISIN: | GB00BYZN9041 |
| Day's Range | 269.80p - 295.20p |
| 52wk Range: | 269.80p - 672.00p |
| Market Capitalisation: | £250.87m |
| VWAP: | 279.86927p |
| Shares in Issue: | 87.59m |
Future (FUTR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 252,970 | 286.40p | Uncrossing Trade |
16:35:18 - 02-Nov-26 |
| Buy* | 29 | 285.00p | SI Trade |
16:29:04 - 02-Nov-26 |
| Sell* | 642 | 284.60p | SI Trade |
16:29:03 - 02-Nov-26 |
| Sell* | 241 | 284.60p | Automatic Execution |
16:27:42 - 02-Nov-26 |
| Sell* | 42 | 284.60p | Automatic Execution |
16:27:42 - 02-Nov-26 |
| Sell* | 200 | 284.60p | Automatic Execution |
16:27:41 - 02-Nov-26 |
| Sell* | 144 | 284.60p | Automatic Execution |
16:27:41 - 02-Nov-26 |
| Sell* | 176 | 284.60p | Automatic Execution |
16:27:41 - 02-Nov-26 |
| Sell* | 382 | 284.60p | Automatic Execution |
16:27:41 - 02-Nov-26 |
| Sell* | 262 | 284.80p | Automatic Execution |
16:26:31 - 02-Nov-26 |
Future (FUTR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Oct 2026 10:38 am | RNS | Holding(s) in Company |
| 7th Oct 2026 3:52 pm | RNS | Holding(s) in Company |
| 7th Oct 2026 3:50 pm | RNS | Holding(s) in Company |
| 6th Oct 2026 9:24 am | RNS | Holding(s) in Company |
| 5th Oct 2026 8:33 am | RNS | Holding(s) in Company |
| 5th Oct 2026 7:00 am | RNS | Transaction in Own Shares |
| 1st Oct 2026 9:49 am | RNS | Total Voting Rights |
| 30th Sep 2026 3:46 pm | RNS | Holding(s) in Company |
| 30th Sep 2026 7:00 am | RNS | Pre-close trading update |
| 28th Sep 2026 8:06 am | RNS | Holding(s) in Company |